{"transactions":[{"id":2201399,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":125108,"kind":"person","name":"Desmarais William","position":1,"cik":"0001860207","reported_name":"Desmarais William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-27T16:30:53.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following July 25, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":30000,"derivative":{"exercise_price":3.27,"expiration_date":"2032-07-24","underlying":"Voting Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-22-026848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860207/000089924322026848/doc4.xml","form_type":"4"}},{"id":2430786,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":125108,"kind":"person","name":"Desmarais William","position":1,"cik":"0001860207","reported_name":"Desmarais William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T16:29:07.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over 4 years of service following January 18, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-17","underlying":"Voting Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-22-002654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860207/000089924322002654/doc4.xml","form_type":"4"}},{"id":2585344,"issuer":{"id":7255,"kind":"organization","name":"TScan Therapeutics, Inc."},"owners":[{"id":125108,"kind":"person","name":"Desmarais William","position":1,"cik":"0001860207","reported_name":"Desmarais William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Voting Common Stock","published_at":"2021-08-31T17:56:45.000Z","date":"2021-08-27","kind":"purchase","acquired":true,"shares":2500,"price":9.0832,"value":22708.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $9.01 to $9.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0000899243-21-034610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860207/000089924321034610/doc4.xml","form_type":"4"}}]}